Daiwa Securities Group Inc. Alvotech Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Alvotech stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 1,030 shares of ALVO stock, worth $8,487. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,030
Previous 1,030
-0.0%
Holding current value
$8,487
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ALVO
# of Institutions
52Shares Held
16.4MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.23MShares$34.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$22.3 Million14.1% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$12.9 Million0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.39MShares$11.5 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$10.9 Million11.48% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.05B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...